Axiscades Technologies Share Price
Sector: Business Services
1425.30 +63.00 (4.62%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1355.00
Today’s High
1430.40
52 Week Low
421.05
52 Week High
1479.00
1426.30 +66.60 (4.90%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
1358.00
Today’s High
1427.60
52 Week Low
420.90
52 Week High
1469.00
Key Metrics
- Market Cap (In Cr) 6013.63
- Beta 0.99
- Div. Yield (%) 0
- P/B 8.9
- TTM P/E 50.3
- Peg Ratio 1.83
- Sector P/E 8.13
- D/E 0
- Open Price 1365
- Prev Close 1362.3
Axiscades Technologies Analysis
Price Analysis
-
1 Week-3.51%
-
3 Months51.41%
-
6 Month114.65%
-
YTD114.48%
-
1 Year147.53%
Risk Meter
- 57% Low risk
- 57% Moderate risk
- 57% Balanced Risk
- 57% High risk
- 57% Extreme risk
Axiscades Technologies News
Stocks to watch: Nestle, HDFC Bank, HCL Tech, CONCOR among shares in focus today
1 min read . 20 Jun 2025Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
2 min read . 07 Mar 2025Diwali 2024 stock picks: Ashika Group recommends 7 stocks with up to 33% upside
6 min read . 21 Oct 2024Q1 Results Today: Tata Power, NCC, PFC, PNC among 132 companies to post earnings
1 min read . 06 Aug 2024Axiscades Technologies Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 1030.72
- Selling/ General/ Admin Expenses Total
- 516.42
- Depreciation/ Amortization
- 39.6
- Other Operating Expenses Total
- 158.46
- Total Operating Expense
- 931.74
- Operating Income
- 98.99
- Net Income Before Taxes
- 87.52
- Net Income
- 74.94
- Diluted Normalized EPS
- 17.98
- Period
- 2025
- Total Assets
- 1127.11
- Total Liabilities
- 478.06
- Total Equity
- 649.06
- Tangible Book Valueper Share Common Eq
- 108.96
- Period
- 2025
- Cashfrom Operating Activities
- 88.34
- Cashfrom Investing Activities
- 8.64
- Cashfrom Financing Activities
- -99.53
- Net Changein Cash
- -3.26
- Period
- 2024
- Total Revenue
- 955.12
- Selling/ General/ Admin Expenses Total
- 635.58
- Depreciation/ Amortization
- 33.79
- Other Operating Expenses Total
- 0.87
- Total Operating Expense
- 858.92
- Operating Income
- 96.21
- Net Income Before Taxes
- 53.02
- Net Income
- 32.81
- Diluted Normalized EPS
- 8.22
- Period
- 2024
- Total Assets
- 1139.11
- Total Liabilities
- 553.75
- Total Equity
- 585.36
- Tangible Book Valueper Share Common Eq
- 93.6
- Period
- 2024
- Cashfrom Operating Activities
- 78.93
- Cashfrom Investing Activities
- -162.74
- Cashfrom Financing Activities
- 63.88
- Net Changein Cash
- -19.46
- Period
- 2023
- Total Revenue
- 813.6
- Selling/ General/ Admin Expenses Total
- 485.8
- Depreciation/ Amortization
- 26.52
- Other Operating Expenses Total
- 1.31
- Total Operating Expense
- 762.82
- Operating Income
- 50.78
- Net Income Before Taxes
- 21.02
- Net Income
- -5.23
- Diluted Normalized EPS
- 10.51
- Period
- 2023
- Total Assets
- 904.38
- Total Liabilities
- 566.31
- Total Equity
- 338.07
- Tangible Book Valueper Share Common Eq
- 51.94
- Period
- 2023
- Cashfrom Operating Activities
- 70.64
- Cashfrom Investing Activities
- -200.81
- Cashfrom Financing Activities
- 132.8
- Net Changein Cash
- 3.97
- Period
- 2022
- Total Revenue
- 608.41
- Selling/ General/ Admin Expenses Total
- 419.2
- Depreciation/ Amortization
- 25.06
- Other Operating Expenses Total
- 0.48
- Total Operating Expense
- 563.1
- Operating Income
- 45.31
- Net Income Before Taxes
- 36.76
- Net Income
- 22.23
- Diluted Normalized EPS
- 6.08
- Period
- 2022
- Total Assets
- 794.4
- Total Liabilities
- 463.14
- Total Equity
- 331.26
- Tangible Book Valueper Share Common Eq
- 50.3
- Period
- 2022
- Cashfrom Operating Activities
- 31.18
- Cashfrom Investing Activities
- 29.58
- Cashfrom Financing Activities
- -42.3
- Net Changein Cash
- 18.4
- Period
- 2021
- Total Revenue
- 517.39
- Selling/ General/ Admin Expenses Total
- 360.06
- Depreciation/ Amortization
- 25.99
- Other Operating Expenses Total
- 0.04
- Total Operating Expense
- 547.13
- Operating Income
- -29.74
- Net Income Before Taxes
- -10.38
- Net Income
- -21.66
- Diluted Normalized EPS
- 5.02
- Period
- 2021
- Total Assets
- 742.36
- Total Liabilities
- 443.75
- Total Equity
- 298.61
- Tangible Book Valueper Share Common Eq
- 42.02
- Period
- 2021
- Cashfrom Operating Activities
- 122.12
- Cashfrom Investing Activities
- -21.77
- Cashfrom Financing Activities
- -92.94
- Net Changein Cash
- 7.92
- Period
- 2020
- Total Revenue
- 664.98
- Selling/ General/ Admin Expenses Total
- 473.27
- Depreciation/ Amortization
- 28.7
- Other Operating Expenses Total
- 1.1
- Total Operating Expense
- 609.66
- Operating Income
- 55.32
- Net Income Before Taxes
- 38.39
- Net Income
- 29.75
- Diluted Normalized EPS
- 8.73
- Period
- 2020
- Total Assets
- 858.57
- Total Liabilities
- 543.44
- Total Equity
- 315.13
- Tangible Book Valueper Share Common Eq
- 28.43
- Period
- 2020
- Cashfrom Operating Activities
- 64.89
- Cashfrom Investing Activities
- -2.93
- Cashfrom Financing Activities
- -48.46
- Net Changein Cash
- 14.2
- Period
- 2019
- Total Revenue
- 604.34
- Selling/ General/ Admin Expenses Total
- 468
- Depreciation/ Amortization
- 19.75
- Other Operating Expenses Total
- 25.75
- Total Operating Expense
- 610.69
- Operating Income
- -6.35
- Net Income Before Taxes
- -8.39
- Net Income
- -8.13
- Diluted Normalized EPS
- -1.73
- Period
- 2019
- Total Assets
- 770.97
- Total Liabilities
- 486.3
- Total Equity
- 284.67
- Tangible Book Valueper Share Common Eq
- 19.07
- Period
- 2019
- Cashfrom Operating Activities
- 37.13
- Cashfrom Investing Activities
- -13.46
- Cashfrom Financing Activities
- -6.52
- Net Changein Cash
- 17.35
- Period
- 2025-03-31
- Total Revenue
- 267.97
- Selling/ General/ Admin Expenses Total
- 129.33
- Depreciation/ Amortization
- 9.56
- Other Operating Expenses Total
- 45.97
- Total Operating Expense
- 242.07
- Operating Income
- 25.9
- Net Income Before Taxes
- 21.42
- Net Income
- 30.76
- Diluted Normalized EPS
- 7.46
- Period
- 2025-03-31
- Total Assets
- 1127.11
- Total Liabilities
- 478.06
- Total Equity
- 649.06
- Tangible Book Valueper Share Common Eq
- 108.96
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 88.34
- Cashfrom Investing Activities
- 8.64
- Cashfrom Financing Activities
- -99.53
- Net Changein Cash
- -3.26
- Period
- 2024-12-31
- Total Revenue
- 274.53
- Selling/ General/ Admin Expenses Total
- 131.93
- Depreciation/ Amortization
- 10.82
- Other Operating Expenses Total
- 38.92
- Total Operating Expense
- 246.47
- Operating Income
- 28.06
- Net Income Before Taxes
- 23.13
- Net Income
- 14.81
- Diluted Normalized EPS
- 3.67
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 264.72
- Selling/ General/ Admin Expenses Total
- 131.75
- Depreciation/ Amortization
- 9.94
- Other Operating Expenses Total
- 36.8
- Total Operating Expense
- 241.71
- Operating Income
- 23.01
- Net Income Before Taxes
- 18.75
- Net Income
- 12.3
- Diluted Normalized EPS
- 2.91
- Period
- 2024-09-30
- Total Assets
- 1115.27
- Total Liabilities
- 507.93
- Total Equity
- 607.34
- Tangible Book Valueper Share Common Eq
- 99.84
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 32.91
- Cashfrom Investing Activities
- 29.16
- Cashfrom Financing Activities
- -82.61
- Net Changein Cash
- -20.61
- Period
- 2024-06-30
- Total Revenue
- 223.51
- Selling/ General/ Admin Expenses Total
- 123.41
- Depreciation/ Amortization
- 9.28
- Other Operating Expenses Total
- 36.76
- Total Operating Expense
- 201.49
- Operating Income
- 22.02
- Net Income Before Taxes
- 24.22
- Net Income
- 17.07
- Diluted Normalized EPS
- 3.77
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 254.06
- Selling/ General/ Admin Expenses Total
- 134.9
- Depreciation/ Amortization
- 9.52
- Other Operating Expenses Total
- 36.82
- Total Operating Expense
- 232.83
- Operating Income
- 21.22
- Net Income Before Taxes
- 15.92
- Net Income
- 8.71
- Diluted Normalized EPS
- 2.05
- Period
- 2024-03-31
- Total Assets
- 1139.11
- Total Liabilities
- 553.75
- Total Equity
- 585.36
- Tangible Book Valueper Share Common Eq
- 93.6
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 78.93
- Cashfrom Investing Activities
- -162.74
- Cashfrom Financing Activities
- 63.88
- Net Changein Cash
- -19.46
- Period
- 2023-12-31
- Total Revenue
- 232.23
- Selling/ General/ Admin Expenses Total
- 132.55
- Depreciation/ Amortization
- 8.49
- Other Operating Expenses Total
- 35.42
- Total Operating Expense
- 210.73
- Operating Income
- 21.49
- Net Income Before Taxes
- 11.03
- Net Income
- 7.43
- Diluted Normalized EPS
- 1.93
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Axiscades Technologies Technical
Moving Average
SMA
- 5 Day1385.45
- 10 Day1307.88
- 20 Day1202.49
- 50 Day1003.46
- 100 Day898.54
- 300 Day735.3
Axiscades Technologies Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Rites
- 280.5
- 1.5
- 0.54
- 398.5
- 192.3
- 13480.94
- Icra
- 6692.75
- 11.9
- 0.18
- 7700
- 5085.9
- 6475.25
- Axiscades Technologies
- 1425.3
- 63
- 4.62
- 1479
- 421.05
- 6013.63
- Care Ratings
- 1771.2
- 17.25
- 0.98
- 1964.8
- 922
- 5288.83
- Sun Pharma Advanced Research Com
- 161.6
- 2
- 1.25
- 257.7
- 109.2
- 5244.27
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Rites
- 34.86
- 5.08
- 18.31
- 20.92
- Icra
- 38.15
- 6.15
- 14.76
- 32.96
- Axiscades Technologies
- 73.64
- 8.67
- 5.06
- 2.68
- Care Ratings
- 39.01
- 6.62
- 14.75
- 32.86
- Sun Pharma Advanced Research Com
- -
- -
- -340.58
- -168.34
Axiscades Technologies Shareholding
Shareholding Pattern
*Promoter pledging: 8.41%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 26-May-25
- Audited Results
- 31-Jan-25
- Quarterly Results
- 12-Nov-24
- Quarterly Results
- 26-Sept-24
- Others
- 06-Aug-24
- Quarterly Results
- 20-May-24
- Audited Results
- 14-Feb-24
- Quarterly Results
- 15-Jan-24
- Others
- 08-Nov-23
- Quarterly Results & Others
- 04-Aug-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 18-Apr-25
- 17-Mar-25
- POM
- 17-Dec-24
- 18-Nov-24
- POM
- 18-Sept-24
- 29-Jul-24
- AGM
- 19-Dec-23
- 17-Nov-23
- POM
- 28-Sept-23
- 05-Sept-23
- AGM
- 04-Apr-23
- 02-Mar-23
- POM
- 27-Sept-22
- 10-Aug-22
- AGM
- 26-May-22
- 22-Apr-22
- POM
- 28-Sept-21
- 07-Aug-21
- AGM
- 29-Sept-20
- 26-Aug-20
- AGM



